Robert Orlowski

Professor

  • 22220 Citations
  • 70 h-Index
1984 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Robert Orlowski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Proteasome Inhibitors Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Proteasome Endopeptidase Complex Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Melphalan Medicine & Life Sciences
Thalidomide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2019

A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

Lee, H. C., Shah, J. J., Feng, L., Manasanch, E. E., Lu, R., Morphey, A., Crumpton, B., Patel, K. K., Wang, M. L., Alexanian, R., Thomas, S. K., Weber, D. M. & Orlowski, R. Z., Oct 1 2019, In : Blood cancer journal. 9, 10, 80.

Research output: Contribution to journalLetter

Open Access
Multiple Myeloma
Dexamethasone
carfilzomib

A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

Lee, H. C., Shah, J. J., Feng, L., Morphey, A., Johnson, R. J., Wesson, E. T., Wang, M. L., Alexanian, R., Thomas, S. K., Orlowski, R. Z. & Weber, D. M., Dec 1 2019, In : American journal of hematology. 94, 12, p. E319-E322

Research output: Contribution to journalLetter

Thalidomide
Multiple Myeloma
Dexamethasone
lenalidomide

A pilot study of pembrolizumab in smoldering myeloma: Report of the clinical, immune, and genomic analysis

Manasanch, E. E., Han, G., Mathur, R., Qing, Y., Zhang, Z., Lee, H., Weber, D. M., Amini, B., Berkova, Z., Eterovic, K., Zhang, S., Zhang, J., Song, X., Mao, X., Morgan, M., Feng, L., Baladandayuthapani, V., Futreal, A., Wang, L., Neelapu, S. S. & 1 others, Orlowski, R. Z., Jan 1 2019, In : Blood Advances. 3, 15, p. 2400-2408 9 p.

Research output: Contribution to journalArticle

Open Access
Bone Marrow
T-Lymphocytes
Interstitial Nephritis
Multiple Myeloma
Transcriptome
1 Citation (Scopus)
Waldenstrom Macroglobulinemia
Multiple Myeloma
Proteasome Inhibitors
Therapeutics
Standard of Care

Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups

Orlowski, R., Moreau, P., Niesvizky, R., Ludwig, H., Oriol, A., Chng, W. J., Goldschmidt, H., Yang, Z., Kimball, A. S. & Dimopoulos, M., Aug 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 8, p. 522-530.e1

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Safety
Survival
Bortezomib